Application of radial basis function networks and successive projections algorithm in a QSAR study of anti-HIV activity for a large group of HEPT derivatives

Journal of Chemometrics

Volumn 20, Issue 1-2, 2006, Pages 1-12

  Akhlaghi, Yousef ^a   Kompany Zareh, Mohsen ^a,b  

^a INSTITUTE FOR ADVANCED STUDIES IN BASIC SCIENCES IASBS   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anti HIV; QSAR; Radial basis function networks; Successive projections algorithm

Indexed keywords

COMPUTATIONAL CHEMISTRY; FORECASTING; MOLECULAR GRAPHICS; MOLECULAR STRUCTURE;

ANTI-HIV; ANTI-HIV ACTIVITY; ANTI-HIV-1 ACTIVITY; CROSS VALIDATION; DESCRIPTORS; LARGE GROUPS; PHENYLTHIO; QUANTITATIVE STRUCTURE-ANTI-HIV-1-ACTIVITY RELATIONSHIP; QUANTITATIVE STRUCTURES; SUCCESSIVE PROJECTIONS ALGORITHM;

RADIAL BASIS FUNCTION NETWORKS;

EID: 33847272257     PISSN: 08869383     EISSN: 1099128X     Source Type: Journal    
DOI: 10.1002/cem.971     Document Type: Article

References (60)

1. De Clercq E. Toward improved anti-HIV chemotherapy. Therapeutic strategies for intervention with HIV infection. J. Med. Chem. 1995; 38: 2491-2517.
2. Hariprasad V, Talele TT, Kulkarni VM. Design and synthesis of a novel series of nonpeptidic HIV-1 protease inhibitors. Pharm. Pharmacol. Commun. 1998; 4: 365-372.
3. Sakai H, Kawamura M, Sakuragi J, Sakuragi S, Shibata R, Ishimoto A, Ono H, Ueda S, Adachi A. Integration is essential for efficient gene expression of human immunodeficiency virus type 1. J. Virol. 1993; 7: 1169-1174.
4. Taddeo B, Haseltine WA, Farnet CM. Integrase mutants of human immunodeficiency virus type 1 with a specific defect in integration. J. Virol. 1994; 68: 8401-8405.
5. Engelman A, Englund G, Orenstein JM, Martin MA, Craigie R. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J. Virol. 1995; 69: 2729-2736.
6. Mitsuya H, Yarchoan R, Broder S. Molecular targets for AIDS therapy. Science 1990; 249: 1533-1544.
7. Baba M, Debyser Z, Shigeta S, De Clercq E. Highly potent and selective inhibition of Human Immunodeficiency Virus Type 1 (HIV- 1) by the HIV-1-specific reverse transcriptase inhibitors. Drugs Future 1992; 17: 891-897.
8. De Clercq E. Trends in drug development for the treatment of AIDS compounds interfering with the initial stages of the HIV replicative cycle. Eur. J. Pharmaceutical Sci. 1994; 2: 4-6.
9. Sandberg JA, Slikker W. Development pharmacology and toxicology of anti-HIV therapeutic agents: dideoxynucleosides. FASEB J. 1995; 9: 1157-1163.
10. Barre'-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguest C, Axler-Blin C, Ve'zinet-Brun F, Rouzioux C, Rozenbaum W, Montagnier L. Isolation of a T-lymphotropic retrovirus from a patient at risk for Acquired Immune Deficiency Syndrome (AIDS). Science 1983; 220: 868-871.
11. Gallo RC, Salahuddin SZ, Popovic M, Shearer GM, Kaplan M, Haynes BF, Palker TJ, Redfeild R, Oleske J, Safai B, White G, Foster P, P D, Markhan PD. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 1984; 224: 500-503.
12. Hu C, Chen K, Shi Q, Kilkuskie RE, Cheng Y, Lee K. Anti-AIDS agents, 10. Acacetin-7-O-β-D-galactopyranoside, an anti-HIV principle from Chrysanthemum morifolium and a structure-activity correlation with some related Flavonoids. J. Nat. Prod. 1994; 57: 42-51.
13. Ishitsuka H, Ohsawa C, Ohiwa T, Umeda I, Suhara Y. Antipicornavirus Flavone Ro 09-0179. Antimicrob. Agents Chemother. 1982; 22: 611-616.
14. Kaul TN, Middletown E, Jr., Ogra PL. Antiviral effect of Flavonoids on human viruses. J. Med. Virol. 1985; 15: 71-79.
15. Vrijsen R, Everaert L, Van Hoof LM, Vlietinck MAJ, Berghe DA, Boeye A. The poliovirus-induced shut-off of cellular protein synthesis persists in the presence of 3-Methylquercetin, a flavonoid which blocks viral protein and RNA synthesis. Antiviral Res. 1987; 7: 35-42.
16. Nagai T, Miyaichi Y, Tomimori T, Suzuki Y, Yamada H. In vivo anti-influenza virus activity of plant Flavonoids possessing inhibitory activity for influenza virus Sialidase. Antiviral Res. 1992; 19: 207-217.
17. Beutler JA, Cardellina JH, Cragg GM. Anti-HIV and Cytotoxic Alkaloids from Buchenavia capitata. J. Nat. Prod. 1992; 55: 207-213.
18. Baba M, Tanaka H, De Clercq E, Pauwels R, Balzarini J, Schols D, Nakashima H, Perno CF, Walker RT, Miyasaka T. Highly specific inhibition of Human Immunodeficiency Virus Type 1 by a Novel 6-substituted Acyclouridine derivative. Biochem. Biophys. Res. Commun. 1989; 165: 1375-1381.
19. Miyasaka T, Tanaka H, Baba M, Hayakawa H, Walker RT, Balzarini J, De Clercq E. A novel lead for specific anti-HIV-1 agents: 1-((2-Hydroxyethoxy) methyl]-6-(phenylthio)thymine. J. Med. Chem. 1989; 32: 2507-2509.
20. De Clercq E. Perspective of non-nucloside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 Infection. Il Farmaco 1999; 54: 26-45.
21. Esnouf R, Ren J, Ross C, Jones Y, Stammers D, Stuart D. Mechanism of inhibition of HIV-1 Reverse Transcriptase by non-nucloside inhibitors. Struct. Boil. 1995; 2: 303-308.
22. Tanaka H, Takashima H, Ubasawa M, Sekiya K, Nitta I, Baba M, Shigata S, Walker RT, DeClercq E, Miyasaka T. Structure-activity relationships of 1-((2-hydroxyethoxy)-methyl]-6-(phenylthio)-thiamine analogues: effect of substitutions at the C-6 Phenyl Ring and the C-5 position on anti-HIV-1 activity. J. Med. Chem. 1992; 35: 337-345.
23. Tanaka H, Takashima H, Ubasawa M, Sekiya K, Nitta I, Baba M, Shigeta S, Walker RT, DeClercq E, Miyasaka T. Synthesis and antiviral activity of deoxy analogous of 1-[(2-hydroxyethoxy)-methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV agents. J. Med. Chem. 1992; 35: 4713-4719.
24. Hansh C, Leo A. Exploring QSAR. Fundamentals and Applications in Chemistry and Biology. American Chemical Society: Washington DC, 1995.
25. Jalali-Heravi M, Parastar F. Use of Artificial Neural Networks in a QSAR study of anti-HFV activity for a large group of HEPT derivatives. J. Chem. Inf. Comp. Sci. 2000; 40: 147-154.
26. Zhu J, Chen D, Wu P. Exporation of Artificial Neural system for simulation of Halogen-Exchange Fluorination reaction. Comput. Chem. 1999; 23: 97-100.
27. Yan A, Jiao G, Hu Z, Fan BT. Use of Artificial Neural Networks to predict the Gas Chromatographic Retention Index Data of Alkyl-benzenes on Carbowax-20M. Comput. Chem. 2000; 24: 171-179.
28. Pompe M, Razinger M, Novic M, Veber M. Modelling of gas chromatographic retention indices using counter-propagation neural networks. Anal. Chim. Acta 1997; 348: 215-221.
29. Walkzak B, Massart DL. Local modelling with Radial Basis Function Networks. Chemom. Intell. Lab. Syst. 2000; 50: 179-198.
30. Tetteh J, Howells SL, Metcalfe E, Suzuki T. Optimisation of radial basis function neural networks using biharmonic spline interpolation. Chemom. Intell. Lab. Syst. 1998; 41: 17-29.
31. Fischbacher C, Jagemann K-U, Danzer K, Müller UA, Papenkordt L, Schüler J. Enhancing Calibration Models for Non-Invasive Near-Infrared Spectroscopical Blood glucose Determination. Fresenious' J. Anal. Chem. 1997; 359: 78-82.
32. Li QF, Yao XJ, Chen XG, Liu MC, Zhang RS, Zhang XY, Hu ZD. Application of artificial neural networks for the simultaneous determination of a mixture of fluorescent dyes by synchronous fluorescence. Analyst 2000; 125: 2049-2053.
33. Pulido A, Ruisanchez I, Rius FX. Radial basis functions applied to the classification of UV-visible spectra. Anal. Chim. Acta 1999; 388: 273-281.
34. Stubbings T, Hutter H. Classification of analytical images with radial basis function networks and forward selection. Chemom. Intell. Lab. Syst. 1999; 49: 163-172.
35. Tetteh J, Metcalfe E, Howells SL. Optimisation of radial basis and backpropagation neural networks for modelling auto-ignition temperature by quantitative-structure property relationships. Chemom. Intell. Lab. Syst. 1996; 32: 177-191.
36. Lohniger H. Evaluation of neural networks based on radial basis functions and their application to the prediction of boiling points from structural parameters. J. Chem. Inf. Comput. Sci. 1993; 33: 736-744.
37. Yao XJ, Zhang XY, Zhang RS, Liu MC, Hu ZD, Fan BT. Prediction of enthalpy of alkanes by the use of radial basis function neural networks. Comput. Chem. 2001; 25: 475-482.
38. Yao XJ, Zhang XY, Zhang RS, Liu MC, Hu ZD, Fan BT. Radial basis function neural network based QSPR for the prediction of critical pressures of substituted benzenes. Comput. Chem. 2002; 26: 159-169.
39. Zupan J, Novic M. General type of a uniform and reversible representation of chemical structures. Anal. Chim. Acta 1997; 348: 409-418.
40. Kompany-Zareh M, Mirzaei M. Genetic algorithm-based method for selecting conditions in multivariate determination of povidone-iodine using hand scanner. Anal. Chim. Acta 2004; 521: 231-236.
41. Araújo MCU, Saldanha TCB, Galvão RKH, Yoneyama T, Chame HC, Visani V. The successive projections algorithm for variable selection in Spectroscopic Multicomponent Analysis. Chemom. Intell. Lab. Syst. 2001; 57: 65-73.
42. Luco JM, Ferretti FH. QSAR based on Multiple Linear Regression and PLS methods for the anti-HIV activity of a large group of HEFT derivatives. J. Chem. Inf. Comp. Sci. 1997; 37: 392-401.
43. Garg R, Gupta SP, Gao H, Babu MS, Debnath AK. Comparative quantitative structure-activity relationship studies on anti-HIV drugs. Chem. Rev. 1999; 99: 3525-3601.
44. Kireev DB, Chretien JR, Griersson DS, Monneret CA. 3D QSAR study of a series of HEPT analogues: the influence of conformational mobility on HIV-1 Reverse Transcriptase inhibition. J. Med. Chem. 1997; 40: 4257-4264.
45. Hannongbua S, Nivesnanond K, Lawtrakul L, Pungpo P, Wolschann P. 3D-quantitative structure-activity relationships of HEPT derivatives as HIV-1 Reverse Transcriptase inhibitors, based on Ab Initio calculations. J. Chem. Inf. Comp. Sci. 2001; 41: 848-855.
46. Bazoui H, Zahouily M, Boulajaaj S, Zakarya D. QSAR for anti-HIV activity of HEPT derivatives. SAR QSAK Environ. Res. 2002; 13: 567-577.
47. Douali L, Villemin D, Cherqaoui D. Neural networks: accurate nonlinear QSAR model for HEPT derivatives. J. Chem. Inf. Comp. Sci. 2003; 43: 1200-1207.
48. Gaudio AC, Montanari CA. HEPT derivatives as non-nucloside inhibitors of HIV-1 Reverse Transcriptase: QSAR studies agree with the crystal structure. J. Comput. Aided Mol. Des. 2002; 16: 287-295.
49. Orr MJL. MATLAB Routines for Subset Selection and Ridged Regression in Linear Neural Networks, Centre for Cognitive Science: Edinburg University, 1996.
50. Tronchet J, Grigorov M, Dolatshahi N, Moriaud F, Weber J. A QSAR study confirming the hereogeneity of the HEPT derivative series regarding their interaction with HIV reverse transcriptase. Eur. J. Med. Chem. 1997; 32: 279-299.
51. Zakarya D, Cherqaoui D, Esseffar M, Villemin D, Cense JM. Application of Neural Networks to structure-sandalwood odour relationships. J. Phys. Org. Chem. 1997; 10: 612-622.
52. Kaliszan R. Quantitative Structur-Chromatographic Retention Relationships, Winefordner JD (ed.). John Wiley & Sons: New York, 1987; Chapter 8, 138.
53. Kier LB, Hall LH. Moleculatr Connectivity in Chemistry and Drug Research, Bawden D (ed.). Research Studies Press LTD: Letchworth, Hertfordshire, England, 1986; Chapter 3, 43.
54. Abraham MH. Scales of solute hydrogen-bonding: their construction and application to physicochemical and biochemical processes. Chem. Soc. Rev. 1993; 22: 73-83.
55. Kubinyi H. QSAR: Hansch Analysis and Related Approaches. VCH: Weinheim, 1993; Chapter 3, 21.
56. Hansch C, Leo A, Hoekman D. Hydrophobic Electronic and Steric Constants, Vol. 2 of Exploring QSAR, Heller SR (ed.). American Chemical Society: Washington DC, 1995; 217-304.
57. Kier L, Hall LH. A differential molecular connectivity index. Quant. Struct.-Act. Relat. 1991; 10: 134-140.
58. Todeschini R, Consonni V. Handbook of Molecular Descriptors, Wiley: Weinheim, 2000.
59. Gramatica P, Corradi M, Consonni V. Modelling and prediction of soil sorption coefficients of non-ionic organic pesticides by molecular descriptors. Chemosphere 2000; 41: 763-777.
60. Hansch C, Zhang L. QSAR of HIV inhibitors. Bioorg. Med. Chem. Lett. 1992; 2: 1165-1169.